Survival outcomes and the role of DNADX ctDNA testing in patients treated with sacituzumab govitecan for metastatic breast cancer
- DOI
- 10.1016/j.esmoop.2025.105828
- Published
- 2025-10
- Container
- ESMO Open
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmoop.2025.105828,
title = {Survival outcomes and the role of DNADX ctDNA testing in patients treated with sacituzumab govitecan for metastatic breast cancer},
author = {S. Morganti and R.J. Kusmick and M.E. Hughes and F. Brasó-Maristany and K. Smith and P. Tarantino and R. Vega-Leon and T. Grinda and F. Pardo and K. Dvir and G.L. Suggs and S. Buck and M. Skeffington and A.C. Garrido-Castro and H.A. Parsons and S.L. Sammons and A. Prat and N.U. Lin and S.M. Tolaney and A. Giordano},
year = {2025},
journal = {ESMO Open},
doi = {10.1016/j.esmoop.2025.105828},
url = {https://doi.org/10.1016/j.esmoop.2025.105828}
}RIS
TY - JOUR TI - Survival outcomes and the role of DNADX ctDNA testing in patients treated with sacituzumab govitecan for metastatic breast cancer AU - S. Morganti AU - R.J. Kusmick AU - M.E. Hughes AU - F. Brasó-Maristany AU - K. Smith AU - P. Tarantino AU - R. Vega-Leon AU - T. Grinda AU - F. Pardo AU - K. Dvir AU - G.L. Suggs AU - S. Buck AU - M. Skeffington AU - A.C. Garrido-Castro AU - H.A. Parsons AU - S.L. Sammons AU - A. Prat AU - N.U. Lin AU - S.M. Tolaney AU - A. Giordano PY - 2025 JO - ESMO Open DO - 10.1016/j.esmoop.2025.105828 UR - https://doi.org/10.1016/j.esmoop.2025.105828 ER -
APA
Morganti, S., Kusmick, R., Hughes, M., Brasó-Maristany, F., Smith, K., Tarantino, P., Vega-Leon, R., Grinda, T., Pardo, F., Dvir, K., Suggs, G., Buck, S., Skeffington, M., Garrido-Castro, A., Parsons, H., Sammons, S., Prat, A., Lin, N., Tolaney, S., & Giordano, A. (2025). Survival outcomes and the role of DNADX ctDNA testing in patients treated with sacituzumab govitecan for metastatic breast cancer. ESMO Open. https://doi.org/10.1016/j.esmoop.2025.105828
Source records
- crossref · retrieved 2026-09-27T09:53:34.110Z